John Glenn - Jun 20, 2024 Form 4/A - Amendment Insider Report for IRADIMED CORP (IRMD)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ John Glenn
Stock symbol
IRMD
Transactions as of
Jun 20, 2024
Transactions value $
$0
Form type
4/A - Amendment
Date filed
4/7/2025, 04:10 PM
Date Of Original Report
Apr 4, 2025
Previous filing
Dec 11, 2023
Next filing
Dec 2, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Options Exercise $0 -5.8K -33.33% $0.00 11.6K Jun 20, 2024 Common Stock 5.8K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 When vested, restricted stock units ("RSUs") are convertible into common stock on a one-for-one basis.
F2 On April 4, 2025, the Reporting Person filed a Form 4, which inadvertently stated in Column 5 of Table II that 5,796 RSUs were acquired instead of disposed. This inadvertent misstatement has been corrected in this amended filing to note that 5,796 RSUs were disposed.
F3 On June 20, 2022, the Reporting Person received RSUs under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the Reporting Person will receive a number of shares of common stock equal to the number of RSUs that have vested.